Editing Tinnitus (section)

===Neuromodulation===
In 2020, information about clinical trials indicated that bimodal neuromodulation may reduce the symptoms of tinnitus. It is a noninvasive technique that involves applying an electrical stimulus to the tongue while also administering sounds.<ref>{{cite journal |last1=Kwon |first1=Diana |title=New Tinnitus Treatment Alleviated Annoying Ringing in the Ears |journal=Scientific American |date=7 October 2020 |volume=2 |issue=6 |pages=None |url=https://www.scientificamerican.com/article/new-tinnitus-treatment-alleviates-annoying-ringing-in-the-ears1/ |publisher=Springer Nature America, Inc.|doi=10.1038/scientificamerican122020-2VzL6BO1nViUY4ozIqWxY8 }}</ref> Equipment associated with the treatments is available through physicians. Studies with it and similar devices continue in several research centers.{{citation needed|date=December 2020}}

In March 2023, the US [[Food and Drug Administration]] (FDA) approved Neuromod's Lenire device as a treatment option for tinnitus.<ref name="George 2023">{{cite web |last1=George |first1=Judy |title=First Bimodal Neuromodulation Device for Tinnitus Gets FDA Nod |website=MedPage Today |date=8 March 2023 |url=https://www.medpagetoday.com/surgery/otolaryngology/103453 |access-date=23 July 2024}}</ref><ref name="Everts 2023">{{cite web |last=Everts |first=Quinn |title=FDA Grants De Novo Approval to Non-Invasive Tinnitus Treatment Device |website=Drug Topics |date=14 March 2023 |url=https://www.drugtopics.com/view/fda-grants-de-novo-approval-to-non-invasive-tinnitus-treatment-device |access-date=23 July 2024}}</ref><ref name="Philpott 2024">{{cite web |last=Philpott |first=Jenna | title=Neuromod inks contract to treat US veterans with tinnitus device |website=Medical Device Network |date=18 June 2024 |url=https://www.medicaldevice-network.com/news/neuromod-inks-contract-to-treat-us-veterans-with-tinnitus-device/ |access-date=23 July 2024}}</ref> In June 2024, the US Department of Veterans Affairs (VA) announced it would begin offering the treatment to veterans with tinnitus, making it the first bimodal neuromodulation device to be awarded a Federal Supply Schedule (FSS) contract from the US Government.<ref name="Philpott 2024" />

Some evidence supports neuromodulation techniques such as [[transcranial magnetic stimulation]],<ref name="Baguley McFerran Hall 2013"/><ref>{{cite journal |last=Meng |first=Z |author2=Liu, S |author3=Zheng, Y |author4= Phillips, JS |title=Repetitive transcranial magnetic stimulation for tinnitus |journal=Cochrane Database of Systematic Reviews |date=5 October 2011 |issue=10 |pages=CD007946 |pmid=21975776 |doi=10.1002/14651858.CD007946.pub2}}</ref> [[transcranial direct current stimulation]], and [[neurofeedback]].{{cn|date=February 2025}}